2016
DOI: 10.1007/s11695-016-2081-8
|View full text |Cite
|
Sign up to set email alerts
|

Short-Term UVB Treatment or Intramuscular Cholecalciferol to Prevent Hypovitaminosis D After Gastric Bypass—a Randomized Clinical Trial

Abstract: In this randomized trial, both interventions, UVB and cholecalciferol, given as an adjunct to oral supplementation in gastric bypass patients, increased the levels of 25[OH]D. Simplicity makes injection therapy suitable for maintaining vitamin D levels during the Nordic winter.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2017
2017
2024
2024

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 20 publications
0
3
0
Order By: Relevance
“…This study was conducted from December to May when sunlight is limited in Sweden to avoid the influence of UV-B radiation, as it is a major source in the process of vitamin D synthesis. The injection group received a single dose of 600,000 IU cholecalciferol vitamin D3 Streuli® (Streuli Pharma AG, Uznach); the dosage was chosen according to earlier studies [ 14 , 17 ]. Patients in both groups were instructed to limit their total diet supplementation to 1400 IU of vitamin D. Diet was not otherwise regulated in either group.…”
Section: Methodsmentioning
confidence: 99%
See 2 more Smart Citations
“…This study was conducted from December to May when sunlight is limited in Sweden to avoid the influence of UV-B radiation, as it is a major source in the process of vitamin D synthesis. The injection group received a single dose of 600,000 IU cholecalciferol vitamin D3 Streuli® (Streuli Pharma AG, Uznach); the dosage was chosen according to earlier studies [ 14 , 17 ]. Patients in both groups were instructed to limit their total diet supplementation to 1400 IU of vitamin D. Diet was not otherwise regulated in either group.…”
Section: Methodsmentioning
confidence: 99%
“…A p value < 0.05 was considered significant. A sample size calculation was based on the increase to 80 mmol/L (SD 18) in 25[OH]D, this in response to an identical dose of intramuscular cholecalciferol as used in the study by Einarsdóttir [ 17 ] and the assumption that the present BPD/DS patients had a baseline value no greater than 50 (as found in our previous work in gastric bypass patients [ 14 ]. In order to demonstrate an increase from 50 to 80 with an SD of 18 and a power index of 95% at p < 0.05, the required sample size was nine patients in each group.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation